HLA-G is described as a non-classical MHC class I molecule that regulates immune homeostasis and shapes innate and adaptive cytotoxic responses. The review frames it as capable of promoting tolerance or facilitating immune escape depending on context.
First-pass extracted concept
HLA-G
Candidate: concept label2 source documents7 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
Human leukocyte antigen-G
Extracted Explainers
What the tool is doing
What problem it solves
What it does not solve
Evidence Snippets
Human leukocyte antigen-G (HLA-G) is a non-classical MHC class I molecule with unique immunomodulatory properties.
The non-classical immune checkpoint HLA-G: a regulatory master switch governing tolerance, evasion, and translational frontiers
Supporting Sources
Source 2primary paperyear unknownPMC
Linked Claims
HLA-G has a context-dependent role, promoting tolerance in transplantation and autoimmunity while contributing to immune evasion in cancer and infection.
Quoted textsource-backed
It exerts a context-dependent role, promoting tolerance in settings such as transplantation and autoimmunity while contributing to immune evasion in cancer and infection
HLA-G is a non-classical MHC class I molecule with immunomodulatory properties.
Quoted textsource-backed
Human leukocyte antigen-G (HLA-G) is a non-classical MHC class I molecule with unique immunomodulatory properties
HLA-G is described as a pivotal regulator of immune homeostasis that shapes innate and adaptive cytotoxic responses.
Quoted textsource-backed
Increasing evidence highlights HLA-G as a pivotal regulator of immune homeostasis, capable of shaping both innate and adaptive cytotoxic responses.
The functional plasticity of HLA-G is shaped by isoform diversity and interplay with other non-classical HLA class I molecules.
Quoted textsource-backed
this functional plasticity is further shaped by its isoform diversity and its interplay with other non-classical HLA class I molecules
Current strategies incorporate or target HLA-G in the treatment of malignancies and autoimmune diseases, and HLA-G has emerging potential as a therapeutic target.
Quoted textsource-backed
We further summarize current strategies that incorporate or target HLA-G in the treatment of malignancies and autoimmune diseases, and highlight its emerging potential as a therapeutic target.
Insights into HLA-G biology can be leveraged in the development of cellular and acellular immunotherapies.
Quoted textsource-backed
these insights can be leveraged in the development of cellular and acellular immunotherapies
HLA-G is presented as a non-classical immune checkpoint and regulatory master switch governing tolerance, evasion, and translational frontiers.